Searched for
ZYCOV D
Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...- NTAGI to soon come out with guidelines on vaccinating kidsZyCoV-D is the first DNA plasmid vaccine in the world , developed indigenously by the company against the Covid-19 virus.
- Zydus Cadila to supply 1 crore doses of ZyCoV-D to govt at Rs 265/doseZydus Cadila will supply 1 crore doses of its vaccine ZyCoV-D, the world's first plasmid DNA vaccine to the government of India at Rs 265 p...
- Zydus Cadila to get clarity on ZyCoV-D Covid vaccine pricing in 1-2 weeks: MD Sharvil PatelOn Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...
- First children-friendly Covid vaccination centreFor more such web stories click on the ET icon below.
- Govt finalises price of Cadila's child Covid vaccine ZyCoV-D, rollout likely soonAccording to sources, the government has negotiated the pricing of the vaccine which is "much lower than what the manufacturers had demande...
- India says government panel looking into new Delta subvariantA panel of experts set up by the Indian government is looking into a Delta coronavirus subvariant that has been detected in the UK
- Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it downThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...
- Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
- Government may earmark a part of Zydus vaccine for sick kidsThe drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...
- NTAGI to soon chalk out roadmap to introduce Zydus Cadila's vaccine in Covid inoculation driveThe indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received Emergency Use Authorisation from the drug ...
- Zydus Cadila seeks approval for its needle-free COVID vaccine ZyCOV-D; here's how it worksAccording to a TOI report, Ahmedabad-based Zydus Cadila, which is also one of the companies developing coronavirus vaccine, has sought emer...
- India's Zydus Cadila applies for emergency use nod for COVID-19 vaccineCoronavirus cases in India dropped from a devastating peak in April and May, however, experts have warned of a third wave and reiterated th...
- Zydus to seek emergency nod for Covid vaccine soonThe company is expected to present phase III data for ZyCoV-D--a plasmid DNA vaccine—to the country’s drug regulatory authority by next wee...
- View: How Department of Biotechnology coordinated India's Covid-19 fightFrom its initial mandate to identify priority development areas in biotechnology, it has been instrumental in creating an academic ecosyste...
- Cadila Healthcare Working on Needle-free, 2-Dose VaccineThe drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...
- Covishield vaccine transport to start in less than 24 hoursKool-Ex, a Mumbai-based cold chain cargo transporter, will deploy close 150 of its reefer trucks to transport these vaccines from the manuf...
- COVID-19 vaccine approval: All risks paid off, proud moment for India, say SII, Bharat BiotechPune-based vaccine major Serum Institute of India (SII) had entered into a collaboration with the University of Oxford and AstraZeneca to m...
- Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityAfter his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the pro...
- Oxford candidate the first Covid vaccine likely to be available in India by end of yearIt is believed that the two local candidates — which are in early stages of human trials — will enter the market with a lag of a few weeks ...
Load More
